Neurobiology Research Unit  
 
 steenh

Steen Hasselbalch

Associate professor, MD, DMSc

Scientific interestsBiography | Publications
Address

Scientific interests

Scientific interests include neuroreceptor imaging in neuropsychiatric and neurodegenerative disorders. Current research projects look into cognitive aspects of the serotonergic transmitter system, and changes in this system in depression and dementia.

 


Biography

2005 -   Associate professor in Clinical Neurobiology, University of Copenhagen, Faculty of Health Sciences 
2003  Doctor of Medical Science (DMSc), University of Copenhagen, Faculty of Health Sciences 
2000 -  Senior researcher at the Neurobiology Research Unit 
1998 -  Senior Hospital Physician, The Memory Clinic, The Neuroscience Centre, Rigshospitalet, Copenhagen
1989 - 1993 Research Assistant, Neurobiology Research Unit
1987 - 1998 Basic medical training and specialist training in Neurology
1987 Medical Graduate, University of Copenhagen, Faculty of Health Sciences

Publications

Total publications in peer-reviewed journals: 53

Publications 2005-2010:
Marner L, Gillings N, Madsen K, Erritzoe D, Baaré WF, Svarer C, Hasselbalch SG, Knudsen GM. Brain imaging of serotonin 4 receptors in humans with [(11)C]SB207145-PET. Neuroimage. 2010 Jan 22. [Epub ahead of print]

Benveniste H, Fowler JS, Rooney WD, Scharf BA, Backus WW, Izrailtyan I, Knudsen GM, Hasselbalch SG, Volkow ND. Cocaine is pharmacologically active in the nonhuman primate fetal brain. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1582-7.

Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab. 2010 Jan;30(1):2-14. Review.

Marner L, Gillings N, Comley RA, Baaré WF, Rabiner EA, Wilson AA, Houle S, Hasselbalch SG, Svarer C, Gunn RN, Laruelle M, Knudsen GM. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo. J Nucl Med. 2009 Jun;50(6):900-8.

Kalbitzer J, Svarer C, Frokjaer VG, Erritzoe D, Baaré WF, Madsen J, Hasselbalch SG, Knudsen GM. A probabilistic approach to delineating functional brain regions. J Nucl Med Technol. 2009 Jun;37(2):91-5.

Hasselbalch SG, Kampmann JP. [Treatment of degenerative dementia disorders--who should be treated?]. Ugeskr Laeger. 2009 Mar 2;171(10):802-5. Danish.

Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, Hashemi SH, Baaré WF, Madsen J, Hasselbalch SG, Kringelbach ML, Mortensen EL, Knudsen GM. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 2009 Apr 1;45(2):280-5.

Marner L, Knudsen GM, Haugbøl S, Holm S, Baaré W, Hasselbalch SG. Longitudinal
assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study. Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):287-93.

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 2008 Mar;4(2):145-53.

Høgh P, Teller AS, Hasselbalch S, Waldemar G. Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: a comparative study. Dement Geriatr Cogn Disord. 2007;24(6):429-33.

Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, Svarer C, Hasselbalch SG, Holm S, Paulson OB, Knudsen GM. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry. 2008 Mar 15;63(6):569-76.

Hasselbalch SG, Madsen K, Svarer C, Pinborg LH, Holm S, Paulson OB, Waldemar G, Knudsen GM. Reduced 5-HT2A receptor binding in patients with mild cognitive impairment. Neurobiol Aging. 2008 Dec;29(12):1830-8.

Hasselbalch SG, Baloyannis S, Denislic M, Dubois B, Oertel W, Rossor M, Tsiskaridze A, Waldemar G. Education and training of European neurologists in dementia. Eur J Neurol. 2007 May;14(5):505-9.

Hasselbalch SG, Hansen ES, Jakobsen TB, Pinborg LH, Lønborg JH, Bolwig TG. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2007 May;115(5):388-94.

Hasselbalch SG, Gyldensted C, Søensen LH, Braendgaard H, Andersen K, Lolk A, Kragh-Sørensen P, Waldemar G. [Diagnostic imaging in dementia evaluation]. Ugeskr Laeger. 2006 Oct 2;168(40):3415-9. Danish.

Vogel A, Mortensen EL, Hasselbalch SG, Andersen BB, Waldemar G. Patient versus informant reported quality of life in the earliest phases of Alzheimer's disease. Int J Geriatr Psychiatry. 2006 Dec;21(12):1132-8.

Linde R, Hasselbalch SG, Topp S, Paulson OB, Madsen PL. Global cerebral blood flow and metabolism during acute hyperketonemia in the awake and anesthetized rat. J Cereb Blood Flow Metab. 2006 Feb;26(2):170-80.

Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S, Bolwig TG, Knudsen GM. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol. 2005 Sep;8(3):391-401.

Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry. 2005 Mar;20(3):238-46.


Address

Neurobiology Research Unit
Rigshospitalet
Blegdamsvej 9
DK-2100 Copenhagen, Denmark
Phone: +45 3545 6712 
Fax: +45 3545 6713
E-mail: steen.hasselbalch#nru.dk